HEPHAISTOS-Pharma
Orsay, France · Founded 2018
- Headquarters
- Orsay
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- hephaistos-pharma.fr
About
HEPHAISTOS-Pharma is a biopharmaceutical company developing 3rd generation TLR4 agonist small-molecule innate immune boosters designed to convert myeloid-rich, immunosuppressive tumors into immunotherapy-responsive tumors. The companys lead drug candidate, HEPHA440, has demonstrated compelling anti-tumor activity across a broad spectrum of preclinical cancer models both as a monotherapy and in combination with checkpoint inhibitors, with clinical trials planned for 2027. Founded in 2018 and headquartered in Orsay, France, HEPHAISTOS-Pharma has secured 10.3M in funding and is backed by investors including Elaia.
Summary
HEPHAISTOS-Pharma is a Biotech company based in Orsay, France, founded in 2018.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...